Last edition
News about Global Pharma
Moon Surgical Showcases Maestro System at NVIDIA GTC Paris During VivaTech 2025
Moon Surgical announced its participation at NVIDIA GTC Paris during VivaTech2025. In collaboration with NVIDIA, Moon Surgical is highlighting the Maestro System as a pioneering example of Physical AI in action—empowering surgical teams across the globe.
Global Pharma | 12/06/2025 | By Manvi | 133
Broad Institute and Bayer Extend Cardiovascular Research Collaboration by 5 years
The Broad Institute and Bayer have extended their decade-long cardiovascular research collaboration by another five years to accelerate precision cardiology through human genomics and novel therapeutic development.
Global Pharma | 12/06/2025 | By Manvi | 127
Azurity Pharmaceuticals has received US FDA approval for XIFYRM, a once-daily IV meloxicam injection for moderate-to-severe pain management in adults, offering a non-opioid alternative for multimodal analgesia.
Global Pharma | 12/06/2025 | By Manvi | 230
Axsome Launches SYMBRAVO in US for Acute Migraine Treatment in Adults
Axsome Therapeutics has announced the US prescription availability of SYMBRAVO (meloxicam and rizatriptan), a novel dual-action treatment for acute migraine with or without aura in adults.
Global Pharma | 11/06/2025 | By Manvi | 345
WuXi Biologics and Virogen Biotechnology Enter Commercial Manufacturing Partnership
WuXi Biologics has announced a strategic partnership with Virogen Biotechnology Inc. to support the commercial manufacturing of VG712, a novel immunotherapy targeting T cell dysregulation.
Global Pharma | 11/06/2025 | By Manvi | 289
GT Medical Technologies Appoints James Leech as Chief Financial and Strategy Officer
GT Medical Technologies announced that James Leech, a seasoned financial and operational life sciences leader, has joined the company as Chief Financial and Strategy Officer.
Global Pharma | 11/06/2025 | By Manvi | 234
FDA-Approved WiSE System Begins US Rollout for Leadless Heart Pacing
In a major milestone for heart failure treatment, the first commercial patients in the US have been successfully implanted with the FDA-approved WiSE® System—marking the beginning of a new chapter in leadless left ventricular endocardial pacing (LVEP) for the treatment of heart failure.
Global Pharma | 11/06/2025 | By Manvi | 154
Okomera Opens Pre-Orders for its First Commercial System 'Ocentra'
Okomera opened pre-orders for its first commercial system, Ocentra, unveiled live at the MPS World Summit in Brussels (10–12 June) and Vivatech Paris (11–14 June).
Global Pharma | 10/06/2025 | By Manvi | 361
Solventum Launches Attest Super Rapid VH2O2 Clear Challenge Pack
Solventum, a global MedTech leader at the forefront of infection prevention innovation, announced the launch of its Attest™ Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack.
Global Pharma | 10/06/2025 | By Manvi | 294
WuXi Biologics and VISEN Pharmaceuticals have initiated the technology transfer for local commercial production of lonapegsomatropin in China, marking a key milestone in their strategic collaboration to advance treatment for pediatric growth hormone deficiency.
Global Pharma | 10/06/2025 | By Manvi | 227
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy